Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
NMTC
#3606
NeuroOne Medical Technologies Corporation Common Stock
0.6
7
-2.90%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-2.90%
Monatliche Änderung
-26.37%
6 month change
-8.22%
Jahresänderung
-40.71%
Vorheriger Schlusskurs
0.6
9
Open
0.6
7
Bid
Ask
Low
0.6
7
High
0.6
7
Volumen
7
Märkte
Aktien
Gesundheitswesen
NMTC
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
TTM
Key stats
Total common shares outstanding
30.81 M
30.84 M
30.86 M
49.82 M
50 M
50.41 M
50.53 M
—
Valuation ratios
Enterprise value
25.73 M
29.07 M
24.36 M
41.03 M
25.87 M
38.23 M
34.74 M
139.87 M
Price to earnings ratio
-1.85
-2.15
-3.18
-3.7
-3.99
-9.87
-3.79
-21.35
Price to sales ratio
5.25
7.67
4.06
4.41
3.47
3.92
3.69
15.49
Price to cash flow ratio
-1.78
-2.41
-3.04
-4.56
-5.43
-12.58
-5.75
-28.32
Price to book ratio
1.11
32.23
2.08
3.05
2.05
5.04
1.49
11.64
Enterprise value to EBITDA ratio
-2.15
-2.52
-2.64
-4.56
-3.21
-5.66
-4.74
-18.18
Profitability ratios
Return on assets %
-0.56
-0.62
0.27
-0.51
-0.14
-0.15
-0.17
-0.97
Return on equity %
-0.92
-4.08
0.61
-2.02
-0.18
-0.23
-0.22
-2.65
Return on invested capital %
-739.75
-683.19
249.54
-413.7
-541.53
-334.79
-242.17
-1 532.19
Gross margin %
34.13
51.81
58.85
55.61
53.94
55.77
54.2
219.52
Operating margin %
-338.34
-1 034.48
52.26
-193.29
-111.23
-50.02
-59.02
-413.57
EBITDA margin %
-330.69
-967.57
-31.32
-187.75
-106.32
-46.87
-56.56
-397.51
Net margin %
-335.14
-1 230.55
54.53
-163.76
-88.49
-59.08
-49.71
-361.04
Liquidity ratios
Quick ratio
1.36
0.9
2.41
1.09
5.8
3.47
5.09
15.45
Current ratio
2.42
2.09
3.64
2.13
7.13
4.44
6.41
20.11
Inventory turnover
—
—
0
0
0
0
0
0.01
Asset turnover
0.16
0.05
0.55
0.25
0.22
0.25
0.3
1.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.09
-0.1
0.01
-0
-0.04
-0.04
-0.06
-0.14
EBIT per share
-0.1
-0.11
-0.04
-0.09
-0.05
-0.03
-0.03
-0.21
EBITDA per share
-0.1
-0.1
-0.03
-0.08
-0.05
-0.03
-0.03
-0.2
Total debt per share
—
—
—
—
—
—
—
—
Cash per share
0.06
0.05
0.04
0.04
0.22
0.16
0.07
0.49
Net current asset value per share
0.15
0.17
0.18
0.12
0.28
0.25
0.16
0.81
Tangible book value per share
0.11
0.03
0.09
0.03
0.22
0.18
0.13
0.56
Working capital per share
0.09
0.09
0.13
0.06
0.24
0.2
0.14
0.63
Book value per share
0.11
0.03
0.1
0.04
0.22
0.18
0.13
0.56
Nachrichten
Best Momentum Stocks to Buy for January 6th
New Strong Buy Stocks for January 6th
NeuroOne beruft Penumbra-Manager Jason Mills in den Verwaltungsrat
NeuroOne appoints Penumbra executive Jason Mills to board
Neuroone Medical: EPS übertrifft Schätzungen - Umsatz besser als erwartet
Neuroone Medical earnings beat, revenue topped estimates
NeuroOne meldet Umsatzwachstum von 907 % – Aktie legt vorbörslich zu
Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises
NeuroOne erhält von der NASDAQ Fristverlängerung zur Erfüllung der Mindestkursanforderung
NeuroOne Medical Technologies receives Nasdaq extension to regain minimum bid price compliance
NeuroOne erhält 180-tägige Fristverlängerung zur Erfüllung der NASDAQ-Anforderungen/n
NeuroOne receives 180-day extension to regain nasdaq compliance